Emerg Infect Dis. 2021 Apr;27(4):1110-1122. doi: 10.3201/eid2704.203612.
Expansion of quinolone-resistant Neisseria meningitidis clone China from sequence type (ST) 4821 clonal complex (CC4821) caused a serogroup shift from serogroup A to serogroup C invasive meningococcal disease (IMD) in China. To determine the relationship among globally distributed CC4821 meningococci, we analyzed whole-genome sequence data from 173 CC4821 meningococci isolated from 4 continents during 1972-2019. These meningococci clustered into 4 sublineages (1-4); sublineage 1 primarily comprised of IMD isolates (41/50, 82%). Most isolates from outside China (40/49, 81.6%) formed a distinct sublineage, the Europe-USA cluster, with the typical strain designation B:P1.17-6,23:F3-36:ST-3200(CC4821), harboring mutations in penicillin-binding protein 2. These data show that the quinolone-resistant clone China has expanded to other countries. The increasing distribution worldwide of serogroup B CC4821 raises the concern that CC4821 has the potential to cause a pandemic that would be challenging to control, despite indirect evidence that the Trumenba vaccine might afford some protection.
耐喹诺酮类药物的脑膜炎奈瑟菌克隆 China 从序列型(ST)4821 克隆复合体(CC4821)扩展,导致中国 A 群脑膜炎奈瑟菌向 C 群侵袭性脑膜炎奈瑟菌病(IMD)的血清型转变。为了确定全球分布的 CC4821 脑膜炎奈瑟菌之间的关系,我们分析了来自 1972 年至 2019 年 4 大洲的 173 株 CC4821 脑膜炎奈瑟菌的全基因组序列数据。这些脑膜炎奈瑟菌聚类为 4 个亚谱系(1-4);亚谱系 1主要由 IMD 分离株组成(41/50,82%)。来自中国以外的大多数分离株(40/49,81.6%)形成了一个独特的亚谱系,即欧洲-美国群,其典型菌株命名为 B:P1.17-6,23:F3-36:ST-3200(CC4821),携带青霉素结合蛋白 2 的突变。这些数据表明,耐喹诺酮类药物的克隆 China 已经扩展到其他国家。B 群 CC4821 在全球的分布越来越广泛,这引起了人们的担忧,即 CC4821 有可能引起难以控制的大流行,尽管有间接证据表明 Trumenba 疫苗可能提供一些保护。